Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems

Bingren Tian; Yumei Liu; Jiayue Liu

doi:10.1016/j.carbpol.2020.116401

journal article Aug 01, 2020

Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems

Bingren Tian Yumei Liu

Jiayue Liu

Carbohydrate Polymers Vol. 242 pp. 116401 · Elsevier BV

View at Publisher Save 10.1016/j.carbpol.2020.116401

Topics

No keywords indexed for this article. Browse by subject →

References

174

[1]

Heidel "Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo" Clinical Cancer Research (2007) 10.1158/1078-0432.ccr-06-2218

[2]

Li "Biocompatible supramolecular pseudorotaxane hydrogels for controllable release of doxorubicin in ovarian cancer SKOV-3 cells" RSC Advances (2020) 10.1039/c9ra08986a

[3]

Schluep "Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice" Cancer Chemotherapy and Pharmacology (2006) 10.1007/s00280-005-0091-7

[4]

Tian "Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review" Carbohydrate Polymers (2020) 10.1016/j.carbpol.2019.115805

[5]

Wang "Facile synthesis of chitosan-grafted beta-cyclodextrin for stimuli-responsive drug delivery" International Journal of Biological Macromolecules (2019) 10.1016/j.ijbiomac.2018.12.150

[6]

Abarca "Characterization of β-cyclodextrin inclusion complexes containing an essential oil component" Food Chemistry (2016) 10.1016/j.foodchem.2015.10.023

[7]

Adeoye "Cyclodextrin nanosystems in oral drug delivery: A mini review" International Journal of Pharmaceutics (2017) 10.1016/j.ijpharm.2017.04.050

[8]

Albers "Cyclodextrin derivatives in pharmaceutics" Critical Reviews in Therapeutic Drug Carrier Systems (1995) 10.1615/critrevtherdrugcarriersyst.v12.i4.20

[9]

Alvira "Molecular dynamics study of the factors influencing the β-Cyclodextrin inclusion complex formation of the isomers of linear molecules" Journal of Chemistry (2017) 10.1155/2017/6907421

[10]

Entering the Modern Era of Gene Therapy

Xavier M. Anguela, Katherine A. High

Annual Review of Medicine 2019 10.1146/annurev-med-012017-043332

[11]

Anirudhan "Synthesis and characterization of silane coated magnetic nanoparticles/glycidylmethacrylate-grafted-maleated cyclodextrin composite hydrogel as a drug carrier for the controlled delivery of 5-fluorouracil" Materials Science and Engineering C (2015) 10.1016/j.msec.2015.05.068

[12]

A review on the use of cyclodextrins in foods

G. Astray, C. González-Barreiro, J.C. Mejuto et al.

Food Hydrocolloids 2009 10.1016/j.foodhyd.2009.01.001

[13]

Li "Synthesis of β-cyclodextrin-PEG-G molecules to delay tumor growth and application of β-cyclodextrin-PEG-G aggregates as drug carrier" Carbohydrate Polymers (2020) 10.1016/j.carbpol.2019.115478

[14]

Schluep "Preclinical efficacy of the camptothecin-polymer conjugate IT-101 in multiple cancer models" Clinical Cancer Research (2006) 10.1158/1078-0432.ccr-05-1566

[15]

Tian "The application and prospects of cyclodextrin inclusion complexes and polymers in the food industry: A review" Polymer International (2020) 10.1002/pi.5992

[16]

Wang "Selective recognition and enrichment of carbamazepine in biological samples by magnetic imprinted polymer based on reversible addition-fragmentation chain transfer polymerization" Journal of Chromatography A (2019) 10.1016/j.chroma.2019.01.057

[17]

Badi "Synthesis of half-channels by the anionic polymerization of ethylene oxide initiated by modified cyclodextrin" Advanced Materials (2009) 10.1002/adma.200802982

[18]

Bai "Reduction-active polymeric prodrug micelles based on α-cyclodextrin polyrotaxanes for triggered drug release and enhanced cancer therapy" Carbohydrate Polymers (2018) 10.1016/j.carbpol.2018.03.097

[19]

Banerjee "Grafting of 2-Hydroxypropyl-β-Cyclodextrin on gum arabic-modified Iron oxide nanoparticles as a magnetic carrier for targeted delivery of hydrophobic anticancer drug" International Journal of Applied Ceramic Technology (2010) 10.1111/j.1744-7402.2008.02332.x

[20]

Bartlett "Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles" Biotechnology and Bioengineering (2008) 10.1002/bit.21668

[21]

Becker "Functional biodegradable polymers via ring-opening polymerization of monomers without protective groups" Chemical Society Reviews (2018) 10.1039/c8cs00531a

[22]

Bibby "Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems" International Journal of Pharmaceutics (2000) 10.1016/s0378-5173(00)00335-5

[23]

Boger "Cyclodextrin chemistry. Selective modification of all primary hydroxyl groups of α- and β-cyclodextrins" Helvetica Chimica Acta (1978) 10.1002/hlca.19780610622

[24]

Boumahdi "The great escape: Tumour cell plasticity in resistance to targeted therapy" Nature Reviews Drug Discovery (2019) 10.1038/s41573-019-0044-1

[25]

Caliceti "Synthesis and physicochemical characterization of folate-cyclodextrin bioconjugate for active drug delivery" Bioconjugate Chemistry (2003) 10.1021/bc034080i

[26]

Chen "Cyclodextrin-based inclusion complexation bridging supramolecular chemistry and macromolecular self-assembly" Chemical Society Reviews (2011) 10.1039/c0cs00153h

[27]

Chen "Cyclodextrin-based bioactive supramolecular assemblies" Chemical Society Reviews (2010) 10.1039/b816354p

[28]

Chen "Host immune response to anti-cancer camptothecin conjugated cyclodextrin-based polymers" Journal of Biomedical Science (2019) 10.1186/s12929-019-0583-0

[29]

Cheng "Selective binding and controlled release of anticancer drugs by polyanionic cyclodextrins" Bioorganic & Medicinal Chemistry (2018) 10.1016/j.bmc.2018.03.013

[30]

Cheng "Antitumor activity of β-Cyclodextrin polymer- camptothecin conjugates" Molecular Pharmaceutics (2004) 10.1021/mp049966y

[31]

Cheng "Synthesis of linear, β-cyclodextrin-based polymers and their camptothecin conjugates" Bioconjugate Chemistry (2003) 10.1021/bc0340924

[32]

Chu "Chemical conjugation with cyclodextrins as a versatile tool for drug delivery" Journal of Inclusion Phenomena and Macrocyclic Chemistry (2017) 10.1007/s10847-017-0743-3

[33]

Ciardiello "Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy" Cancer Treatment Reviews (2019) 10.1016/j.ctrv.2019.04.003

[34]

Çirpanli "Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery" European Journal of Pharmaceutics and Biopharmaceutics (2009) 10.1016/j.ejpb.2009.04.013

[35]

Cragg "Impact of natural products on developing new anti-cancer agents" Chemical Reviews (2009) 10.1021/cr900019j

[36]

Croft "Synthesis of chemically modified cyclodextrins" Tetrahedron (1983) 10.1016/s0040-4020(01)88551-3

[37]

Cross "Gene therapy for cancer treatment: Past, present and future" Clinical Medicine & Research (2006) 10.3121/cmr.4.3.218

[38]

Da Rocha "Natural products in anticancer therapy" Current Opinion in Pharmacology (2001) 10.1016/s1471-4892(01)00063-7

[39]

da Rocha Neto "Factors affecting the entrapment efficiency of β-cyclodextrins and their effects on the formation of inclusion complexes containing essential oils" Food Hydrocolloids (2018) 10.1016/j.foodhyd.2017.10.029

[40]

Davis "Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin" Advanced Drug Delivery Reviews (2009) 10.1016/j.addr.2009.05.005

[41]

Davis "Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles" Nature (2010) 10.1038/nature08956

[42]

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

Catherine de Martel, Damien Georges, Freddie Bray et al.

The Lancet Global Health 2020 10.1016/s2214-109x(19)30488-7

[43]

de Melo "Interaction pathways of specific co-solvents with hydroxypropyl-β-cyclodextrin inclusion complexes with benznidazole in liquid and solid phase" Journal of Molecular Liquids (2016) 10.1016/j.molliq.2016.08.042

[44]

de Vries Schultink "An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome" Breast Cancer Research and Treatment (2017) 10.1007/s10549-016-4083-6

[45]

Del Valle "Cyclodextrins and their uses: A review" Process Biochemistry (2004) 10.1016/s0032-9592(03)00258-9

[46]

Delaittre "Nitroxide-mediated aqueous dispersion polymerization: From water-soluble macroalkoxyamine to thermosensitive nanogels" Macromolecular Rapid Communications (2007) 10.1002/marc.200700230

[47]

Duncan "Cultivable bacterial diversity from the human colon" Letters in Applied Microbiology (2007) 10.1111/j.1472-765x.2007.02129.x

[48]

Elamin "Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer" International Journal of Biological Macromolecules (2018) 10.1016/j.ijbiomac.2018.02.149

[49]

El-Zeiny "Insight into novel β-cyclodextrin-grafted-poly (N-vinylcaprolactam) nanogel structures as advanced carriers for 5-fluorouracil: Equilibrium behavior and pharmacokinetic modeling" Colloids and Surfaces A, Physicochemical and Engineering Aspects (2020) 10.1016/j.colsurfa.2019.124197

[50]

Erdoğar "Improved oral bioavailability of anticancer drug tamoxifen through complexation with water soluble cyclodextrins: In vitro and in vivo evaluation" Journal of Inclusion Phenomena and Macrocyclic Chemistry (2020) 10.1007/s10847-019-00952-4

Showing 50 of 174 references

Cited By

55

“On‐Off” Switching of Functional Guest Molecules via Exchange of Natural Product Solubilizing Agents

Riku Kawasaki, Atsushi Ikeda · 2023

ChemBioChem

Metrics

55

Citations

174

References

Details

Published: Aug 01, 2020
Vol/Issue: 242
Pages: 116401
License: View

Authors

Cite This Article

Bingren Tian, Yumei Liu, Jiayue Liu (2020). Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems. Carbohydrate Polymers, 242, 116401. https://doi.org/10.1016/j.carbpol.2020.116401

Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems

You May Also Like